Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergei Leonov

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|November 21, 2007
Discussion of the "White Paper of the PhRMA PISC Working Group on adaptive dose-ranging designs"Sergei Leonov
Journal of Biopharmaceutical Statistics|September 22, 2007
Population pharmacokinetic measures, their estimation and selection of sampling timesValerii Fedorov, Sergei Leonov
Journal of Biopharmaceutical Statistics|February 13, 2009
An adaptive optimal design for the E(max) model and its application in clinical trialsSergei Leonov, Sam Miller
Journal of Biopharmaceutical Statistics|February 11, 2005
Optimal population designs for PK models with serial samplingRobert Gagnon, Sergei Leonov
Pharmaceutical Statistics|February 27, 2007
Sample size calculation for the Power Model for dose proportionality studiesVenkat S Sethuraman, Sergei Leonov, Lisa Squassante, et al.
British Journal of Clinical Pharmacology|February 20, 2014
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studiesJoakim Nyberg, Caroline Bazzoli, Kay Ogungbenro, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|November 21, 2007
Discussion of the "White Paper of the PhRMA PISC Working Group on adaptive dose-ranging designs"Sergei Leonov
Journal of Biopharmaceutical Statistics|September 22, 2007
Population pharmacokinetic measures, their estimation and selection of sampling timesValerii Fedorov, Sergei Leonov
Journal of Biopharmaceutical Statistics|February 13, 2009
An adaptive optimal design for the E(max) model and its application in clinical trialsSergei Leonov, Sam Miller
Journal of Biopharmaceutical Statistics|February 11, 2005
Optimal population designs for PK models with serial samplingRobert Gagnon, Sergei Leonov
Pharmaceutical Statistics|February 27, 2007
Sample size calculation for the Power Model for dose proportionality studiesVenkat S Sethuraman, Sergei Leonov, Lisa Squassante, et al.
British Journal of Clinical Pharmacology|February 20, 2014
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studiesJoakim Nyberg, Caroline Bazzoli, Kay Ogungbenro, et al.
Pageof 1